Updates in Emergency Management of Stroke / AMI. Dr Daniel Chor Associate Consultant, NUH EMD MBBS (S pore), MCEM (UK), M.
|
|
- Barnaby Paul
- 5 years ago
- Views:
Transcription
1 Updates in Emergency Management of Stroke / AMI Dr Daniel Chor Associate Consultant, NUH EMD MBBS (S pore), MCEM (UK), M.Med (EM) (S pore)
2 Emergency Management Outline of today s talk Stats on Stroke Part 1: Stroke Goals of Treatment What is new? What we do at NUH
3 Emergency Management Outline of today s talk Stats on AMI Part 2: Acute Myocardial Infarction STEMI equivalents Management and update in therapies What we do at NUH
4 Part 1: Stroke
5 Outline Statistics on Stroke in Singapore Goals of treatment What is new? Early imaging Early intervention What we do at NUH
6 Some Statistics on Stroke ~80% Ischaemic Overall increasing trends in number of stroke cases from Average duration of admission: 8 to 10 days National Registry of Disease Office.
7 Medical cost of stroke Study published in 2015 in International Journal of Stroke Random sampling of patients with stroke Annual mean cost of a patient with ischaemic stroke ~$9000 Ng CS, Toh MPHS, Ng J, et al. Direct medical cost of stroke in Singapore. Int J Stroke 2015; 10:
8 Goals of treatment Time is essential Early Suspicion Assessment Stabilisation Early imaging Early intervention What is new?
9 Early Suspicion FAST: Sensitivity 83% Specificity 68% CPSS: Sensitivity 85% Specificity 69% Higher the sensitivity, the more effective the screening tool! Purrucker JC, Hametner C, Engelbrecht A et al. Comparison of stroke recognition and stroke severity scores for stroke detection in a single cohort. J Neurol Neurosurg Psychiatry Sep; 86(9):1021-8
10 Early Assessment Time of onset Nature of symptoms Ruling out potential mimics Migraine / SAH / ICH Bell s palsy Hypoglycaemia Syncope Seizure Drug toxicity
11 Early Assessment Loss of higher functions such as changes in behavior, aphasia, memory impairment and neglect usually suggest major vessel involvement
12 Early Assessment
13 Early Assessment Bedside tests Hypocount ECG Lab tests Full Blood Count Troponin Renal Panel Coagulation profile Other labs for differentials
14 Early Stablisation Assessing vitals signs Stabilise ABC Reversal of potential mimics eg hypoglycaemia Fluid resuscitation / reversal of dehydration
15 Early imaging In acute setting: Exclude haemorrhage Assess extent of injury to brain Identify site of vascular occlusion Assess infarct core, salvageable brain tissue and degree of collateral circulation
16 Early imaging Non-contrast CT (NCCT) CT Angriogram / CT perfusion MRI Pros Readily available Rapid acquisition of images Very sensitive at evaluating for haemorrhage Evaluate vasculature (occlusion / collaterals) Evaluation of infarct core and salvageable brain tissue Detects more acute ischaemic strokes Cons Not sensitive in detecting acute ischaemic stroke Less readily available than NCCT Takes longer than NCCT Contrast required Many contraindications Less tolerable Less available More costly Takes more time
17 Early imaging Alberta Stroke Program Early CT Score (ASPECTS) method Method of assessing ischaemic changes on a CT brain Helps identify patients unlikely to benefit from thrombolysis Using 2 standard axial CT cuts Essentially divides MCA territory into 10 regions 1 point subtracted for an early ischaemic change Score of 7 associated with poorer outcomes Barber PA, Demchuk AM, Zhang J et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355(9216):1670.
18 Early Intervention Reperfusion therapy: Aim to restore blood flow to parts of brain that are ischaemic Need to present early enough 2 main modalities Intravenous Thrombolysis (1 st line) Mechanical Thrombectomy
19 Early Intervention IV Thrombolysis Main agent used: Alteplase (or recombinant Tissue Plasminogen Activator - rtpa) Initiates local fibrinolysis Converts plasminogen to plasmin -> breaks down fibrinogen and fibrin in the clot
20 Early Intervention IV Thrombolysis Given if occurring within 4.5 hours of symptom onset Symptom onset taken as time last seen well Benefits are time dependent Benefits Within 3 hours of onset: Good outcome seen in 33% of patients vs 23% given placebo Treated between 3 to 4.5 hours: Proportion of good outcomes was 35% vs 30% Risks risk of symptomatic ICH (6.8% vs 1.3%) and fatal ICH within 7 days (2.7% vs 0.4%) Allergy / angioedema Emberson J, Lees KR, Lyden P et al. Effect of treatment delay, age and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):
21 Early Intervention IV Thrombolysis Overall percentage of patients receiving thrombolysis from 0.5% in 2005 to 6.5% in
22 Early Intervention IV Thrombolysis
23 Early Intervention IV Thrombolysis Recommended Door-to-needle time of 60 minutes Evaluation by Dr within 10 minutes of ED arrival Activation of stroke specialist 15 minutes Imaging 25 minutes Interpretation 45 minutes Start of therapy by 60 minutes Powers WJ, Rabinstein AA, Ackerson T, et al Guidelines for the Early Management of Patients with Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association / American Stroke Association. Stroke. 2018;49(3):e46-e110
24 Early Intervention IV Thrombolysis Some other points rtpa dose: 0.9mg/kg over 60 minutes with 10% as a bolus over 1 minute May require BP control prior should be <185/110 Neurological deficits should be measurable and persistent Close neurologic and cardiac monitoring in a stroke unit required Powers WJ, Rabinstein AA, Ackerson T, et al Guidelines for the Early Management of Patients with Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association / American Stroke Association. Stroke. 2018;49(3):e46-e110
25 Early Intervention Mechanical Thrombectomy Main indication: Large arterial occlusion in the anterior circulation Treated within 24 hours of symptom onset Can (and should) receive IV rtpa if eligible Some grey indications: Posterior circulation occlusions eg affecting Vertebral / Basilar Arteries
26 Early Intervention Mechanical Thrombectomy 5 multicenter, open label RCTs published in 2015 Evaluating mechanical thrombectomy within 6 hours of symptom onset Early intra-arterial treatment with 2 nd generation mechanical thrombectomy devices were: Safe and effective for reducing disability Superior to IV thrombolysis alone for ischaemic strokes 2 to a large artery occlusion in the proximal anterior circulation NNT for functional independence: 3 to 8
27 Early Intervention Mechanical Thrombectomy Meta-analysis of the trials showed: Rate of functional independence in the intervention group significantly greater Significantly reduced disability at 90 days NO significant difference in: rates of symptomatic ICH 90-day mortality Goyal M, Menon BK, van Zwam WH et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723.
28 Early Intervention Mechanical Thrombectomy Meta-analysis of the trials also showed: Beneficial across wide range of patient subgroups including: Age 80 years old High initial stroke severity Those not treated with IV rtpa NNT to reduce disability by at least 1 point: 2.6 Goyal M, Menon BK, van Zwam WH et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723.
29 Early Intervention Mechanical Thrombectomy Benefits of later treatment Possible benefits beyond 6 hours for selected patients who have disproportionately severe clinical deficit relative to volume of infarction on imaging. May benefit patients with wake-up strokes
30 Early Intervention Mechanical Thrombectomy Findings of both studies Primary outcome Adverse events DAWN trial 1 DEFUSE 3 trial 2 Rate of functional independence at 90-days: 49% vs 13% NNT: 3 No significant difference in: Rate of symptomatic intracranial hemorrhage (6% vs 3%) 90-day mortality (19% vs 18%) Rate of functional independence at 90-days: 45% vs 17% NNT: 3.6. Trend to lower mortality with intervention (14% versus 26%). No significant difference in: Rate of symptomatic intracranial hemorrhage (7% vs 4%) Serious adverse events (43% vs 53%). 1 Nogueira RG, Jadhav AP, Haussen DC et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11. 2 Albers GW, Marks MP, Kemp S et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018:378(8):708.
31 Early Intervention Mechanical Thrombectomy Adverse events include: Symptomatic ICH Distal embolisation Dissection Vasospasm Bleeding from puncture Technical success without clinical improvement
32 What we do at NUH Systemic interventions Stroke Nurses, Dedicated Stroke Dr and Neuro-interventionist on Call 24/7 Pre-notified Stroke cases from SCDF ambulance directly into CT room Stroke team also on standby Weighing bed outside CT room CT brain with angiogram perfusion scans available 24/7
33 What we do at NUH Systemic interventions (continued) IV rtpa started in EMD and continued to Neurology HD NUH serving as a hub for stroke management Acute interventions: <4.5 hours: IV rtpa 4.5 up to 6 hours: Mechanical Thrombectomy 6 to 16 hours: KIV Mechanical Thrombectomy
34 Take Homes Early Suspicion Time of onset Nature of symptoms Call SCDF ambulance Allows resource mobilisation Patients presenting within 4.5 hours of symptoms may be eligible for IV Thrombolysis Patients up to 16 hours may still benefit from acute interventions Even wake-up strokes may undergo mechanical thrombectomy
35 Part 2: Acute Myocardial Infarction
36 Outline Statistics on AMI in Singapore STEMI equivalents Management Update in therapies What we do in NUH
37 Some statistics on AMI 1 of the top 3 causes of death in Singapore Common symptoms: chest pain, SOB and diaphoresis National Registry of Disease Office.
38 STEMI equivalents Classical STEMI definition: ST-elevation at the J Point in 2 contiguous leads
39 STEMI equivalents Posterior MI Lt Main Coronary Artery (LMCA) Occlusion De Winter s T Waves Sgarbossa s Criteria Wellens Syndrome Life In The Fast Lane.
40 STEMI equivalents Posterior MI Suggests occlusion of distal Lt Cx or PDA of RCA Findings in V1-V3: Flat ST-Depression Upright T-wave Prominent R wave
41 STEMI equivalents LMCA Occlusion Findings: ST elevation in avr ST elevation in avr V1 Widespread ST depression, esp I, II, V4-V6
42 STEMI equivalents De Winter s T Waves Suggests plad artery occlusion Findings mainly in V1-V4: Upsloping ST segment depression at J-point Tall, symmetric T waves in precordial leads
43 STEMI equivalents Sgarbossa s Criteria Used to identify STEMI in the setting of LBBB or pacemaker Score of 3: > 90% specific for AMI
44 STEMI equivalents Wellens Syndrome Suggests critical plad stenosis In the setting of chest pain, will benefit from early PCI Findings in V1-V4: Biphasic T-waves (Type A) OR Deep symmetric T-waves (Type B)
45 STEMI equivalents Wellens Syndrome (Type A)
46 STEMI equivalents Wellens Syndrome (Type B)
47 Management Focus of therapy Relieve pain ECG and Appropriate monitoring Stabilise haemodynamics Reduce ischaemia MONA? Early PCI
48 Update in therapies Morphine Generally avoided now unless severe pain Large retrospective observational study of >50,000 patients with NSTEMI / ACS Use of morphine associated with higher mortality Meine TJ, Roe MT, Chen AY et al. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J Jun;149(6):
49 Update in therapies Oxygen May be given if SpO2 <90% or clear respiratory distress No added benefit from giving O2 in patients who had SpO2 >90% - does not decrease All-cause mortality Recurrent ischaemia / AMI Heart failure Occurrences of arrhythmias Abuzaid A, Fabrizio C, Felpel K et al. Oxygen Therapy in Patients with Acute myocardial Infarction: A Systematic Review and Meta-Analysis. Am J Med. 2018;131(6):693.
50 Update in therapies Oxygen 2015 AVOID study RCT where STEMI patients with normoxia given 8L/min vs no supplementation No improvement in infarct size In fact, there was increase in: Rate of recurrent MI Frequency of cardiac arrhythmia Infarct size on cardiac MRI at 6 months Stub D, Smith K, Bernard S et al. Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction. Circulation. 2015;131(24):2143.
51 Update in therapies Nitrates Sublingual easily administered IV given if: Persistent chest pain after x3 SL doses Hypertension / Heart failure Avoided if: Hypotensive / risk of hypotension RV infarction Severe Aortic Stenosis Use of phosphodiesterase inhibitors in last 24 hours
52 Update in therapies Antiplatelet Therapy 3 main types (based on mechanism): COX inhibitors: Aspirin Platelet P2Y12 receptor blockers: Clopidogrel, Ticagrelor, Prasugrel GPIIb/IIIa inhibitors: Abciximab, eptifibatide, tirofiban
53 Update in therapies Antiplatelet Therapy (continued) Usually DAPT regardless of subsequent treatment modality but esp for PCI Aspirin Back bone of therapy 300mg as a loading dose 2 nd agent usually P2Y12 inhibitor 3 main ones used now: Clopidogrel, Ticagrelor and Prasugrel
54 Update in therapies Antiplatelet Therapy (continued) Clopidogrel previously mainstay (PCI-CLARITY) Ticagrelor (PLATO) / Prasugrel (Triton-TIMI) preferred now Faster onset More intense platelet inhibition compared to Clopidogrel
55 Update in therapies Antiplatelet Therapy (continued)
56 Update in therapies Antiplatelet Therapy (continued)
57 Update in therapies Early PCI PCI being the mainstay if available Aim for Door-to-Balloon (D2B) time <90 minutes associated with reduced mortality If at a non-pci site, to aim D2B <120 minutes by transfer to a PCI-capable site Stenting preferred over balloon angioplasty Drug Eluting Stents preferred over Bare-metal stents but requires 1 year of DAPT Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13. Borja Ibanez, Stefan James, Stefan Agewall et al ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J Jan 7;39(2):
58 What we do at NUH Systemic interventions Cardiology Interventionist on duty 24/7 Pre-hospital transmission of ECGs by SCDF Facilitates activation of Interventionist Mobilise team and preparation of facility ECG within 10 minutes of arrival Target D2B <90 minutes DAPT: Aspirin + Ticagrelor / Prasugrel Regular audits of performance and adjustment of processes
59 What we do at NUH Some NUH Stats
60 What we do at NUH Some NUH Stats
61 Take Homes Early ECG Look for the STEMI equivalents Call SCDF ambulance Facilitates ECG transmission Allows resource mobilisation Morphine and Oxygen may not be helpful Load Aspirin DAPT = Aspirin + Ticagrelor/Prasugrel/Clopidogrel Reinforce compliance to DAPT
62 Questions?
63 Thank You
Update on Early Acute Ischemic Stroke Interventions
Update on Early Acute Ischemic Stroke Interventions Diana Goodman MD Lead Neurohospitalist Maine Medical Center Assistant Professor of Neurology, Tufts University School of Medicine I have no disclosures
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More informationACUTE ISCHEMIC STROKE
ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE HHS Stroke Annual Review March 7 and March 8, 2018 Objectives To review the stroke endovascular mechanical thrombectomy evidence
More informationAcute Coronary Syndrome
Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with
More informationProtocol for IV rtpa Treatment of Acute Ischemic Stroke
Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and
More informationManagement of Acute Myocardial Infarction
Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care
More informationFrom interventional cardiology to cardio-neurology. A new subspeciality
From interventional cardiology to cardio-neurology. A new subspeciality in the future? Prof. Andrejs Erglis, MD, PhD Pauls Stradins Clinical University Hospital University of Latvia Riga, LATVIA Disclosure
More informationBelinda Green, Cardiologist, SDHB, 2016
Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens
More informationWhen the learner has completed this module, she/he will be able to:
Thrombolytics and Myocardial Infarction WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017
More informationCurrent Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach
Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationWhat oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
More informationNeuro-vascular Intervention in Stroke. Will Adams Consultant Neuroradiologist Plymouth Hospitals NHS Trust
Neuro-vascular Intervention in Stroke Will Adams Consultant Neuroradiologist Plymouth Hospitals NHS Trust Stroke before the mid 1990s Swelling Stroke extension Haemorrhagic transformation Intravenous thrombolysis
More informationStroke: The First Critical Hour. Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP
Stroke: The First Critical Hour Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP Disclosures We have no actual or potential conflicts of interest in relation to this presentation. Objectives Discuss
More informationRBWH ICU Journal Club February 2018 Adam Simpson
RBWH ICU Journal Club February 2018 Adam Simpson 3 THROMBOLYSIS Reperfusion therapy has become the mainstay of therapy for ischaemic stroke. Thrombolysis is now well accepted within 4.5 hours. - Improved
More informationGUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
More informationBroadening the Stroke Window in Light of the DAWN Trial
Broadening the Stroke Window in Light of the DAWN Trial South Jersey Neurovascular and Stroke Symposium April 26, 2018 Rohan Chitale, MD Assistant Professor of Neurological Surgery Vanderbilt University
More informationChest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham
Chest pain and troponins on the acute take J N Townend Queen Elizabeth Hospital Birmingham 3 rd Universal Definition of Myocardial Infarction Type 1: Spontaneous MI related to atherosclerotic plaque rupture
More informationEndovascular Treatment Updates in Stroke Care
Endovascular Treatment Updates in Stroke Care Autumn Graham, MD April 6-10, 2017 Phoenix, AZ Endovascular Treatment Updates in Stroke Care Autumn Graham, MD Associate Professor of Clinical Emergency Medicine
More informationNEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association
NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki 2013, American Heart Association 1 Dr. Doug Kosmicki Reperfusion Strategies Disclosure Information Report any disclosure information of conflicts of interest.
More informationCase 1 5/26/2017 ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE
ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE Rhonda Whiteman Racing Against the Clock Workshop June 1, 2017 Objectives To discuss the hyperacute ischemic stroke management
More informationOptimal antiplatelet and anticoagulant therapy for patients treated in STEMI network
Torino 6 Joint meeting with Mayo Clinic Great Innovation in Cardiology 14-15 Ottobre 2010 Optimal antiplatelet and anticoagulant therapy for patients treated in STEMI network Diego Ardissino Ischemic vs
More informationGuideline for STEMI. Reperfusion at a PCI-Capable Hospital
MANSOURA. 2015 Guideline for STEMI Reperfusion at a PCI-Capable Hospital Mahmoud Yossof MANSOURA 2015 Reperfusion Therapy for Patients with STEMI *Patients with cardiogenic shock or severe heart failure
More informationUpdated and Guideline Based Treatment of Patients with STEMI
Updated and Guideline Based Treatment of Patients with STEMI Eli I. Lev, MD Director, Cardiac Catheterization Laboratory Hasharon Hospital, Rabin Medical Center Associate Professor of Cardiology Tel-Aviv
More informationContinuing Medical Education Post-Test
Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on
More information2018 Early Management of Acute Ischemic Stroke Guidelines Update
2018 Early Management of Acute Ischemic Stroke Guidelines Update Brandi Bowman, PhC, Pharm.D. April 17, 2018 Pharmacist Objectives Describe the recommendations for emergency medical services and hospital
More informationUnclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018
Unclogging The Pipes Zahraa Rabeeah MD Chief Resident February 9,2018 Please join Polleverywhere by texting: ZRABEEAH894 to 37607 Disclosures None Objectives Delineate the differences between TPA vs thrombectomy
More informationAcute coronary syndromes
Acute coronary syndromes 1 Acute coronary syndromes Acute coronary syndromes results primarily from diminished myocardial blood flow secondary to an occlusive or partially occlusive coronary artery thrombus.
More informationDiagnosis and Management of Acute Myocardial Infarction
Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that
More informationCritical Review Form Therapy Objectives: Methods:
Critical Review Form Therapy Clinical Trial Comparing Primary Coronary Angioplasty with Tissue-Plasminogen Activator for Acute Myocardial Infarction (GUSTO-IIb), NEJM 1997; 336: 1621-1628 Objectives: To
More informationCVA Updates Karen Greenberg, DO, FACOEP. Director Neurologic Emergency Department Crozer Chester Medical Center
CVA Updates 2018 Karen Greenberg, DO, FACOEP Director Neurologic Emergency Department Crozer Chester Medical Center Disclosure I have the following financial relationship with the manufacturer of any commercial
More informationAcute Coronary Syndromes
Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management
More informationInterventional Stroke Treatment
Interventional Stroke Treatment Vishal B. Jani MD Medical Director Vascular Neurology Consultant Interventional Neurology CHI Health Assistant Professor, Creighton University School of Medicine Omaha,
More informationSTEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology
STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post
More informationMechanical thrombectomy in Plymouth. Will Adams. Will Adams
Mechanical thrombectomy in Plymouth Will Adams Will Adams History Intra-arterial intervention 1995 (NINDS) iv tpa improved clinical outcome in patients treated within 3 hours of ictus but limited recanalisation
More informationSTEMI Presentation and Case Discussion. Case #1
STEMI Presentation and Case Discussion Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando, Florida September 17 th,
More informationStroke Treatment Beyond Traditional Time Windows. Rishi Gupta, MD, MBA
Stroke Treatment Beyond Traditional Time Windows Rishi Gupta, MD, MBA Director, Stroke and Neurocritical Care Endovascular Neurosurgery Wellstar Health System THE PAST THE PRESENT 2015 American Heart Association/American
More informationOtamixaban for non-st-segment elevation acute coronary syndrome
Otamixaban for non-st-segment elevation acute coronary syndrome September 2011 This technology summary is based on information available at the time of research and a limited literature search. It is not
More informationLearning Objectives. Epidemiology of Acute Coronary Syndrome
Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet
More informationDisclosure. Advances in Interventional Neurology. Disclosure. Natural History of Disease 3/15/2018. Vishal B. Jani MD
Advances in Interventional Neurology Disclosure Vishal B. Jani MD Medical Director Vascular Neurology Consultant Interventional Neurology CHI Health Assistant Professor, Creighton University School of
More informationMaximising Delivery of Thrombectomy
Maximising Delivery of Thrombectomy Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals Visiting Professor of Clinical
More informationMedical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the
More informationCindy Stephens, MSN, ANP Kelly Walker, MS, ACNP Peter Cohn, MD, FACC
Cindy Stephens, MSN, ANP Kelly Walker, MS, ACNP Peter Cohn, MD, FACC Define Acute Coronary syndromes Explain the Cause Assessment, diagnosis and therapy Reperfusion for STEMI Complications to look for
More informationLow Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1)
Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1) Caitlin C. Akerman, PharmD PGY2 Cardiology Resident WakeMed Health & Hospitals Raleigh,
More informationEmergency Room Procedure The first few hours in hospital...
Emergency Room Procedure The first few hours in hospital... ER 5 level Emergency Severity Index SOP s for Stroke Stroke = Level 2 Target Time = 1 Hour 10 min from door 2 Doctor 25 min from door 2 CT 60
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :
More informationDECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck.
DECLARATION OF CONFLICT OF INTEREST Lecture fees: AstraZeneca, Ely Lilly, Merck. Risk of stopping dual therapy. S D Kristensen, FESC Aarhus Denmark Acute coronary syndrome: coronary thrombus Platelets
More informationENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist
ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist Pharmacy Grand Rounds 26 July 2016 2015 MFMER slide-1 Learning
More informationPRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE
PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE Walid Sawalha MD, MBBS (Lond), MRCP(UK)* ABSTRACT Objectives:
More informationACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke
ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center
More informationAdvances in Neuro-Endovascular Care for Acute Stroke
Advances in Neuro-Endovascular Care for Acute Stroke Ciarán J. Powers, MD, PhD, FAANS Associate Professor Program Director Department of Neurological Surgery Surgical Director Comprehensive Stroke Center
More informationAcute brain vessel thrombectomie: when? Why? How?
Acute brain vessel thrombectomie: when? Why? How? Didier Payen, MD, Ph D Université Paris 7 Département Anesthesiologie-Réanimation Univ Paris 7; Unité INSERM 1160 Hôpital Lariboisière AP-HParis current
More informationGuideline scope Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (update)
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Stroke and transient ischaemic attack in over s: diagnosis and initial management (update) 0 0 This will update the NICE on stroke and
More informationStephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland
Advances in Antiplatelet Therapy in PCI and ACS Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland Targets for Platelet
More informationST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set
Form Title Form Number CH-0454 2018, Alberta Health Services, CKCM This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The license does not
More informationTicagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial
compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and
More informationTicagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial
compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial Outcomes in patients with and planned PCI Ph.Gabriel Steg*, Stefan James, Robert A
More informationHorizon Scanning Centre November 2012
Horizon Scanning Centre November 2012 Cangrelor to reduce platelet aggregation and thrombosis in patients undergoing percutaneous coronary intervention99 SUMMARY NIHR HSC ID: 2424 This briefing is based
More informationEmergency Treatment of Ischemic Stroke
Emergency Treatment of Ischemic Stroke JEFFREY BOYLE, M.D., PHD CLINICAL DIRECTOR OF STROKE AT AVERA MCKENNAN AVERA MEDICAL GROUP NEUROLOGY SIOUX FALLS, SD Conflicts of Interest None I will discuss therapies
More informationMechanical thrombectomy beyond the 6 hours. Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital
Mechanical thrombectomy beyond the 6 hours Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital Disclosures None Worldwide statistics 1 IN 6 people will have a stroke at some
More informationEndovascular stroke research after MRCLEAN. W. van Zwam
1 Endovascular stroke research after MRCLEAN W. van Zwam 2 Layout 1. What do we know by now 2. Next research questions Anesthesia Aspiration 3. Ongoing and future research Dutch initiatives 3 4 N=70 Intervention
More informationPerils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion
Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion Aman B. Patel, MD Robert & Jean Ojemann Associate Professor Director, Cerebrovascular Surgery Director, Neuroendovascular
More informationAsif Serajian DO FACC FSCAI
Anticoagulation and Antiplatelet update: A case based approach Asif Serajian DO FACC FSCAI No disclosures relevant to this talk Objectives 1. Discuss the indication for antiplatelet therapy for cardiac
More informationFacilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?
Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction Is it beneficial to patients? Seung-Jea Tahk, MD. PhD. Suwon, Korea Facilitated PCI.. background Degree of coronary flow at
More informationPharmaco-Invasive Approach for STEMI
Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),
More informationThe Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium
The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications
More information2010 ACLS Guidelines. Primary goals of therapy for patients
2010 ACLS Guidelines Part 10: Acute Coronary Syndrome Present : 內科 R1 鍾伯欣 Supervisor: F1 吳亮廷 991110 Primary goals of therapy for patients of ACS Reduce the amount of myocardial necrosis that occurs in
More informationAcute Coronary Syndrome (ACS) Initial Evaluation and Management
Acute Coronary Syndrome (ACS) Initial Evaluation and Management Symptoms of Possible ACS Chest discomfort with or without radiation to the arm(s), jaw, or epigastrium Short of breath Weakness Diaphoresis
More informationTable 1. Specific changes to the FDA labeling for recombinant tissue plasminogen activator (Alteplase, Activase, Genentech, inc).
Acute Ischemic Stroke Controversies Steven R. Messé, MD, FAAN Associate professor of Neurology, Pereleman School of Medicine at the University of Pennsylvania, Philadelphia, PA Using the term controversy
More informationEmergency Department Management of Acute Ischemic Stroke
Emergency Department Management of Acute Ischemic Stroke R. Jason Thurman, MD Associate Professor of Emergency Medicine and Neurosurgery Associate Director, Vanderbilt Stroke Center Vanderbilt University,
More informationFastTest. You ve read the book now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to
More informationTime delays in instituting thrombolysis in acute myocardial infarction - a Singapore perspective
Hong Kong Journal of Emergency Medicine Time delays in instituting thrombolysis in acute myocardial infarction - a Singapore perspective M Tiru and SH Goh The reduction of mortality from acute myocardial
More informationStroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012
Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model
More informationMyocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
More informationQuale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor
Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor Leonardo Bolognese Cardiovascular Department, Arezzo, Italy Platelet Reactivity in Patients with STEMI Undergoing Primary PCI Campo G et
More informationCardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008.
Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008. ST Elevation Myocardial Infarction (STEMI)-Acute Coronary Syndrome Guidelines:
More informationThe Effect of Diagnostic Catheter Angiography on Outcomes of Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment
The Effect of Diagnostic Catheter Angiography on Outcomes of Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Adnan I. Qureshi, MD 1, Muhammad A. Saleem, MD 1, Emrah Aytaç, MD
More informationAcute myocardial infarction. Cardiovascular disorders. main/0202_new 02/03/06. Search date August 2004 Nicholas Danchin and Eric Durand
main/0202_new 02/03/06 Acute myocardial infarction Search date August 2004 Nicholas Danchin and Eric Durand QUESTIONS Which treatments improve outcomes in acute myocardial infarction?...4 Which treatments
More informationThrombolysis administration
Thrombolysis administration Liz Mackey Stroke Nurse Practitioner Western Health Sunshine & Footscray Hospital, Melbourne Thanks ASNEN committee members Skye Coote, Acute Stroke Nurse, Eastern Health (slide
More informationHow to give thrombolysis in acute myocardial infarction
Page 1 of 6 How to give thrombolysis in acute myocardial infarction Original article: Michael Tam In the major urban hospitals, there will be little place for thrombolysis in acute STEMI (STelevation myocardial
More informationPatient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough
Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough Current Management Strategies for ACS ACS No ST Elevation ST ST Elevation Elevation Early Invasive Early Conservative Fibrinolysis
More informationAcute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
More informationST-elevation myocardial infarctions (STEMIs)
Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve
More informationOUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.
OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral
More informationAIMS: CHEST PAIN. Causes of chest pain. Causes of chest pain: Cardiac causes: Acute coronary syndromes pericarditis thoracic aortic dissection
CHEST PAIN Dr Susan Hertzberg Emergency Department Prince of Wales Hospital AIMS: To identify causes of chest pain in patients presenting to the ED. To identify and risk stratify patients presenting with
More informationEffect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden
More informationSupplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
More informationBackground. Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association An Scientific Statement from the Stroke Council, American Heart Association and American Stroke Association
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST How to manage antiplatelet treatment in patients with diabetes in acute coronary syndrome Lars Wallentin Professor of Cardiology, Chief Researcher Cardiovascular Science
More informationUpdated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข
Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Emergency start at community level: Prehospital care Acute stroke
More informationACUTE STROKE IMAGING
ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University
More informationFrom STEMIs to Stents: Updates in PCI practice
From STEMIs to Stents: Updates in PCI practice Arnold Seto, MD, MPA Assistant Clinical Professor, UC-Irvine and Long Beach VA Director of Interventional Cardiology Research Hospitalizations in the U.S.
More informationAcute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine
Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute
More informationNstemi But Stemi-De Winters Sign
Cardiology and Angiology: An International Journal 3(3): 162-166, 2015, Article no.ca.2015.015 ISSN: 2347-520X SCIENCEDOMAIN international www.sciencedomain.org Nstemi But Stemi-De Winters Sign Prem Krishna
More informationMedicine Dr. Omed Lecture 2 Stable and Unstable Angina
Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel
More informationChapter 3 for 12 Lead Training -Precourse-
ONTARIO BASE HOSPITAL GROUP Chapter 3 for 12 Lead Training -Precourse- Ontario Base Hospital Group Education Subcommittee 2008 TIME IS MUSCLE ONTARIO BASE HOSPITAL GROUP Introduction and Purpose Introduction
More information2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction Ramzi Khalil MD FACC Assistant Professor Allegheny Gen.Hospital AHN Speakers
More informationRandomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction
Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction The Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4
More informationThrombolysis in Acute Myocardial Infarction
CHAPTER 70 Thrombolysis in Acute Myocardial Infarction J. S. Hiremath Introduction Reperfusion of the occluded coronary artery at the earliest is the most important aim of management of STEMI. Once a flow
More informationClinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
More information